|
|
|
|
Дата |
|---|
| 10.04.2025 |
| 09.04.2025 |
| 08.04.2025 |
| 07.04.2025 |
| 06.04.2025 |
| 03.04.2025 |
| 02.04.2025 |
| 27.03.2025 |
| 26.03.2025 |
| 25.03.2025 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
|---|---|---|---|---|---|---|---|
|
|
|
50.00
|
50.15
|
51.25
|
50.99
|
|
|
8 566 003.66
|
222.00
|
|
|
|
50.05
|
49.71
|
50.79
|
50.00
|
|
|
13 845 069.76
|
303.00
|
|
|
|
50.05
|
49.90
|
50.48
|
50.05
|
|
|
4 192 214.94
|
146.00
|
|
|
|
50.00
|
49.02
|
50.19
|
50.05
|
|
|
8 162 883.76
|
367.00
|
|
|
|
50.49
|
48.33
|
50.20
|
50.00
|
|
|
18 808 126.84
|
547.00
|
|
|
|
50.63
|
50.05
|
51.29
|
50.49
|
|
|
1 090 314.89
|
142.00
|
|
|
|
50.99
|
50.04
|
51.50
|
50.63
|
|
|
3 583 390.61
|
266.00
|
|
|
|
50.99
|
50.04
|
51.50
|
50.63
|
|
|
3 583 390.61
|
266.00
|
|
|
|
50.57
|
50.50
|
51.50
|
50.99
|
|
|
15 524 376.40
|
353.00
|
|
|
|
50.97
|
49.90
|
51.30
|
50.57
|
|
|
19 515 563.77
|
402.00
|
Период |
|---|
| 2022, регулярные |
| 2020, регулярные |
| 2018, регулярные |
| 2017, регулярные |
| 2016, регулярные |
| 2015, регулярные |
| 2012, регулярные |
| 2011, регулярные |
| 2010, регулярные |
|
Экс-дивидендная дата
|
Закрытие реестра |
Сумма выплаты |
|---|---|---|
|
13.04.2023
|
18.04.2023 |
2 EGP |
|
21.04.2021
|
25.04.2021 |
2.95 EGP |
|
02.05.2019
|
05.05.2019 |
4 EGP |
|
06.04.2018
|
10.04.2018 |
4.5 EGP |
|
08.05.2017
|
09.05.2017 |
3.5 EGP |
|
21.04.2016
|
24.04.2016 |
3.5 EGP |
|
23.04.2013
|
24.04.2013 |
3 EGP |
|
24.05.2012
|
27.05.2012 |
3 EGP |
|
29.04.2011
|
02.05.2011 |
2.5 EGP |
Egyptian International Pharmaceuticals Industries Co SAE (EIPICO) is an Egypt-based public shareholding company that operates in the pharmaceuticals industry. The Company is a manufacturer and exporter of pharmaceuticals, and holds license agreements with a group of international pharmaceutical companies to produce their products locally and replace the imported ones. The Company produces dosage forms, such as spansule capsules (long-acting), as well as non-traditional dosage forms, such as the soft gelatin capsules, lyophilized products, gels, sprayers and effervescent tablets
